• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小型人工结合蛋白(亲和素)对糖苷酶的强效特异性抑制作用。

Potent and specific inhibition of glycosidases by small artificial binding proteins (affitins).

作者信息

Correa Agustín, Pacheco Sabino, Mechaly Ariel E, Obal Gonzalo, Béhar Ghislaine, Mouratou Barbara, Oppezzo Pablo, Alzari Pedro M, Pecorari Frédéric

机构信息

Institut Pasteur de Montevideo, Recombinant Protein Unit, Montevideo, Uruguay; Institut Pasteur, Unité de Microbiologie Structurale, CNRS UMR 3528, Paris, France.

Institut Pasteur, Unité de Microbiologie Structurale, CNRS UMR 3528, Paris, France; INSERM UMR 892 - CRCNA, Nantes, France; CNRS UMR 6299, Nantes, France; University of Nantes, Nantes, France.

出版信息

PLoS One. 2014 May 13;9(5):e97438. doi: 10.1371/journal.pone.0097438. eCollection 2014.

DOI:10.1371/journal.pone.0097438
PMID:24823716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4019568/
Abstract

Glycosidases are associated with various human diseases. The development of efficient and specific inhibitors may provide powerful tools to modulate their activity. However, achieving high selectivity is a major challenge given that glycosidases with different functions can have similar enzymatic mechanisms and active-site architectures. As an alternative approach to small-chemical compounds, proteinaceous inhibitors might provide a better specificity by involving a larger surface area of interaction. We report here the design and characterization of proteinaceous inhibitors that specifically target endoglycosidases representative of the two major mechanistic classes; retaining and inverting glycosidases. These inhibitors consist of artificial affinity proteins, Affitins, selected against the thermophilic CelD from Clostridium thermocellum and lysozyme from hen egg. They were obtained from libraries of Sac7d variants, which involve either the randomization of a surface or the randomization of a surface and an artificially-extended loop. Glycosidase binders exhibited affinities in the nanomolar range with no cross-recognition, with efficient inhibition of lysozyme (Ki = 45 nM) and CelD (Ki = 95 and 111 nM), high expression yields in Escherichia coli, solubility, and thermal stabilities up to 81.1°C. The crystal structures of glycosidase-Affitin complexes validate our library designs. We observed that Affitins prevented substrate access by two modes of binding; covering or penetrating the catalytic site via the extended loop. In addition, Affitins formed salt-bridges with residues essential for enzymatic activity. These results lead us to propose the use of Affitins as versatile selective glycosidase inhibitors and, potentially, as enzymatic inhibitors in general.

摘要

糖苷酶与多种人类疾病相关。开发高效且特异性的抑制剂可能会为调节其活性提供有力工具。然而,鉴于具有不同功能的糖苷酶可能具有相似的酶促机制和活性位点结构,实现高选择性是一项重大挑战。作为小分子化合物的替代方法,蛋白质类抑制剂可能通过涉及更大的相互作用表面积而提供更好的特异性。我们在此报告了针对两种主要机制类型的代表性内切糖苷酶(保留型和转化型糖苷酶)的蛋白质类抑制剂的设计与表征。这些抑制剂由人工亲和蛋白Affitins组成,它们是针对来自嗜热栖热放线菌的嗜热CelD和来自鸡蛋的溶菌酶筛选得到的。它们是从Sac7d变体文库中获得的,该文库涉及表面随机化或表面及人工延伸环的随机化。糖苷酶结合剂表现出纳摩尔范围内的亲和力且无交叉识别,能有效抑制溶菌酶(Ki = 45 nM)和CelD(Ki = 95和111 nM),在大肠杆菌中表达产量高、具有溶解性且热稳定性高达81.1°C。糖苷酶 - Affitin复合物的晶体结构验证了我们的文库设计。我们观察到Affitins通过两种结合模式阻止底物进入;通过延伸环覆盖或穿透催化位点。此外,Affitins与酶活性必需的残基形成盐桥。这些结果使我们提议将Affitins用作通用的选择性糖苷酶抑制剂,并有可能用作一般的酶抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/dbfe9b273b6d/pone.0097438.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/bbc4ef074063/pone.0097438.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/3560f50daf32/pone.0097438.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/bf8a55d2baae/pone.0097438.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/9d2f2c9fb71f/pone.0097438.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/cbc2b9230813/pone.0097438.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/4bfb8b701802/pone.0097438.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/a0d5513b142a/pone.0097438.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/dbfe9b273b6d/pone.0097438.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/bbc4ef074063/pone.0097438.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/3560f50daf32/pone.0097438.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/bf8a55d2baae/pone.0097438.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/9d2f2c9fb71f/pone.0097438.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/cbc2b9230813/pone.0097438.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/4bfb8b701802/pone.0097438.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/a0d5513b142a/pone.0097438.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c4b/4019568/dbfe9b273b6d/pone.0097438.g008.jpg

相似文献

1
Potent and specific inhibition of glycosidases by small artificial binding proteins (affitins).小型人工结合蛋白(亲和素)对糖苷酶的强效特异性抑制作用。
PLoS One. 2014 May 13;9(5):e97438. doi: 10.1371/journal.pone.0097438. eCollection 2014.
2
Affinity transfer to the archaeal extremophilic Sac7d protein by insertion of a CDR.通过插入互补决定区将亲和力转移至古生嗜极端微生物的Sac7d蛋白
Protein Eng Des Sel. 2014 Oct;27(10):431-8. doi: 10.1093/protein/gzu042.
3
Tolerance of the archaeal Sac7d scaffold protein to alternative library designs: characterization of anti-immunoglobulin G Affitins.古菌 Sac7d 支架蛋白对替代文库设计的耐受性:抗免疫球蛋白 G Affitins 的特性。
Protein Eng Des Sel. 2013 Apr;26(4):267-75. doi: 10.1093/protein/gzs106. Epub 2013 Jan 11.
4
Structural basis of the conversion of T4 lysozyme into a transglycosidase by reengineering the active site.通过对活性位点进行重新设计将T4溶菌酶转化为转糖基酶的结构基础。
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8949-54. doi: 10.1073/pnas.96.16.8949.
5
Exchange of active site residues alters substrate specificity in extremely thermostable β-glycosidase from Thermococcus kodakarensis KOD1.活性位点残基的交换改变了来自嗜热栖热菌KOD1的极端耐热β-糖苷酶的底物特异性。
Enzyme Microb Technol. 2015 Sep;77:14-20. doi: 10.1016/j.enzmictec.2015.05.002. Epub 2015 May 18.
6
Fullerene-sp2-iminosugar balls as multimodal ligands for lectins and glycosidases: a mechanistic hypothesis for the inhibitory multivalent effect.富勒烯-sp2-亚氨基糖球作为凝集素和糖苷酶的多模式配体:抑制多价效应的机制假说。
Chemistry. 2013 Dec 2;19(49):16791-803. doi: 10.1002/chem.201303158. Epub 2013 Oct 22.
7
Structure of Acidothermus cellulolyticus family 74 glycoside hydrolase at 1.82 Å resolution.嗜热栖热放线菌74家族糖苷水解酶在1.82 Å分辨率下的结构
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Dec;69(Pt 12):1335-8. doi: 10.1107/S1744309113030005. Epub 2013 Nov 28.
8
Chitinolytic enzymes: catalysis, substrate binding, and their application.几丁质分解酶:催化作用、底物结合及其应用
Curr Protein Pept Sci. 2000 Jul;1(1):105-24. doi: 10.2174/1389203003381450.
9
Engineering novel S-glycosidase activity into extremo-adapted β-glucosidase by rational design.通过合理设计,将新型 S-糖苷酶活性引入极端适应的β-葡萄糖苷酶中。
Appl Microbiol Biotechnol. 2020 May;104(10):4407-4415. doi: 10.1007/s00253-020-10582-3. Epub 2020 Mar 30.
10
DNA family shuffling of hyperthermostable beta-glycosidases.超嗜热β-糖苷酶的DNA家族改组
Biochem J. 2002 Dec 1;368(Pt 2):461-70. doi: 10.1042/BJ20020726.

引用本文的文献

1
Complete preclinical evaluation of the novel antibody mimetic Nanofitin-IRDye800CW for diverse non-invasive diagnostic applications in the management of HER-2 positive tumors.新型抗体模拟物Nanofitin-IRDye800CW在HER-2阳性肿瘤管理中的多种非侵入性诊断应用的完整临床前评估。
Sci Rep. 2025 Mar 21;15(1):9832. doi: 10.1038/s41598-025-93696-w.
2
Engineering and Structural Elucidation of a Sac7d-Derived IgG Fc-Specific Affitin and Its Application for the Light-Controlled Affinity Purification of Antibodies.源自Sac7d的IgG Fc特异性亲和体的工程设计与结构解析及其在光控抗体亲和纯化中的应用
Chembiochem. 2025 Jun 3;26(11):e202500102. doi: 10.1002/cbic.202500102. Epub 2025 Apr 7.
3

本文引用的文献

1
Generation of a vector suite for protein solubility screening.用于蛋白质可溶性筛选的载体套件的生成。
Front Microbiol. 2014 Feb 25;5:67. doi: 10.3389/fmicb.2014.00067. eCollection 2014.
2
Tracking molecular recognition at the atomic level with a new protein scaffold based on the OB-fold.利用基于OB折叠的新型蛋白质支架在原子水平追踪分子识别。
PLoS One. 2014 Jan 20;9(1):e86050. doi: 10.1371/journal.pone.0086050. eCollection 2014.
3
Tolerance of the archaeal Sac7d scaffold protein to alternative library designs: characterization of anti-immunoglobulin G Affitins.
Recent Applications of In Silico Approaches for Studying Receptor Mutations Associated with Human Pathologies.
近年来,基于计算机的方法在研究与人类疾病相关的受体突变中的应用。
Molecules. 2024 Nov 13;29(22):5349. doi: 10.3390/molecules29225349.
4
Nanofitins and their applications in human health and lung diseases.纳米适配体及其在人类健康和肺部疾病中的应用。
Mol Ther. 2023 Oct 4;31(10):2813-2814. doi: 10.1016/j.ymthe.2023.09.009. Epub 2023 Sep 19.
5
Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tract.可吸入纳米菲特通过直接在呼吸道应用展示了对 SARS-CoV-2 病毒的高中和作用。
Mol Ther. 2023 Oct 4;31(10):2861-2871. doi: 10.1016/j.ymthe.2023.08.010. Epub 2023 Aug 30.
6
CD98hc is a target for brain delivery of biotherapeutics.CD98hc 是脑内递送生物治疗药物的靶点。
Nat Commun. 2023 Aug 19;14(1):5053. doi: 10.1038/s41467-023-40681-4.
7
Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft Model.靶向纳米菌素-药物偶联物在 EGFR 阳性小鼠异种移植模型中实现高效肿瘤递送和治疗效果。
Mol Cancer Ther. 2023 Nov 1;22(11):1343-1351. doi: 10.1158/1535-7163.MCT-22-0805.
8
Design of an artificial phage-display library based on a new scaffold improved for average stability of the randomized proteins.基于新支架设计的人工噬菌体展示文库,该支架可提高随机化蛋白的平均稳定性。
Sci Rep. 2023 Jan 24;13(1):1339. doi: 10.1038/s41598-023-27710-4.
9
Evaluation of docking procedures reliability in affitins-partners interactions.抗肌动蛋白与配体相互作用中对接程序可靠性的评估。
Front Chem. 2022 Dec 1;10:1074249. doi: 10.3389/fchem.2022.1074249. eCollection 2022.
10
Protein scaffolds: antibody alternatives for cancer diagnosis and therapy.蛋白质支架:用于癌症诊断和治疗的抗体替代物。
RSC Chem Biol. 2022 May 25;3(7):830-847. doi: 10.1039/d2cb00094f. eCollection 2022 Jul 6.
古菌 Sac7d 支架蛋白对替代文库设计的耐受性:抗免疫球蛋白 G Affitins 的特性。
Protein Eng Des Sel. 2013 Apr;26(4):267-75. doi: 10.1093/protein/gzs106. Epub 2013 Jan 11.
4
Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study.治疗糖尿病性黄斑水肿的设计锚重复蛋白,与血管内皮生长因子结合:一项 I/II 期研究。
Am J Ophthalmol. 2013 Apr;155(4):697-704, 704.e1-2. doi: 10.1016/j.ajo.2012.09.032. Epub 2012 Dec 4.
5
Novel protein scaffolds as emerging therapeutic proteins: from discovery to clinical proof-of-concept.新型蛋白支架作为新兴治疗性蛋白:从发现到临床概念验证。
Trends Biotechnol. 2012 Nov;30(11):575-82. doi: 10.1016/j.tibtech.2012.07.006. Epub 2012 Sep 1.
6
Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology.开发糖基化酶抑制剂作为糖生物学研究工具。
Nat Chem Biol. 2012 Jul 18;8(8):683-94. doi: 10.1038/nchembio.1029.
7
Therapeutic proteins.治疗性蛋白质
Methods Mol Biol. 2012;899:1-26. doi: 10.1007/978-1-61779-921-1_1.
8
Studies on α-glucosidase inhibitors development: magic molecules for the treatment of carbohydrate mediated diseases.α-葡萄糖苷酶抑制剂的研究进展:碳水化合物介导疾病治疗的神奇分子。
Mini Rev Med Chem. 2012 Jul;12(8):713-20. doi: 10.2174/138955712801264837.
9
Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold.教旧支架新招:使用 FN3 支架的替代表面构建单域抗体。
J Mol Biol. 2012 Jan 13;415(2):393-405. doi: 10.1016/j.jmb.2011.12.019. Epub 2011 Dec 16.
10
Ribosome display for the selection of Sac7d scaffolds.用于筛选Sac7d支架的核糖体展示技术。
Methods Mol Biol. 2012;805:315-31. doi: 10.1007/978-1-61779-379-0_18.